Clinical Efficacy of the Unani Formulation Majoon‑e‑Ushba with a Polyherbal Sufoof in Early‑Stage Rheumatoid Arthritis: A Case Series Analysis
Abstract
Background: Rheumatoid arthritis (RA) is a chronic autoimmune disorder causing pain, stiffness, and disability. Conventional therapies are effective but limited by adverse effects. Unani medicine offers polyherbal formulations such as Majoon‑e‑Ushba (MU), traditionally prescribed for Waja ‘al Mafāṣil.
Objectives: To assess the efficacy and safety of Majoon‑e‑Ushba (MU), with adjunct Unani powders in early RA, stratified by serological status.
Methods: A prospective, open‑label case series at Ajmal Khan Tibbiya College & Hospital enrolled five patients (Stage 1–2 RA) based on ACR/EULAR 2020 criteria (three RF/ACPA positive, two seronegative). Majoon‑e‑Ushba (6 g twice daily) plus a powder blend (Colchicum luteum, Trigonella foenum graecum, Nigella sativa, Lepidium sativum) was administered for 8 weeks.
Outcomes: It included VAS pain, stiffness, joint counts, and inflammatory markers. Results: Significant improvements were observed: VAS 7.4 ± 1.1 to 3.2 ± 0.8 (t=9.21, p<0.001); stiffness 45 ± 12 to 12 ± 5 min (t=8.74, p<0.001); joint counts 6.8 ± 2.3 to 2.0 ± 1.1 (t=7.95, p<0.001); ESR and CRP declined (p<0.01). One seronegative patient achieved remission.
Conclusion: Majoon‑e‑Ushba with adjunct powders produced statistically significant clinical and laboratory improvements in both seropositive and seronegative RA, supporting traditional claims of immunomodulatory and bone‑protective effects. Larger controlled trials are warranted.
Keywords: Rheumatoid arthritis (RA), Majoon‑e‑Ushba, Unani medicine, Polyherbal formulation.
Keywords:
Rheumatoid arthritis (RA), Majoon e Ushba, Unani medicine, Polyherbal formulationDOI
https://doi.org/10.22270/jddt.v16i8.7923References
1) Loscalzo J, Kasper DL, Longo DL, Fauci AS, Hauser SL, Jameson JL, editors. Harrison’s Principles of Internal Medicine. 21st ed. Vol. 1. New York: McGraw Hill LLC; 2022. p. 2752 2753. ISBN: 978 1 26 426851 1.
2) Munjal YP, editor in chief. API Textbook of Medicine. 9th ed. Mumbai: The Association of Physicians of India; 2012. p. 1829. ISBN: 978 93 5025 074 7.
3) Bashir F, Khan AA, Akhtar J, Anjum N, Alam S. (2019). CONCEPT AND MANAGEMENT OF WAJA ‘AL-MAFᾹSIL (ARTHRITIS) IN UNANI SYSTEM OF MEDICINE. Journal of Drug Delivery and Therapeutics, 9(2-s):634-9. https://doi.org/10.22270/jddt.v9i2-s.2699
4) Ibn Sina. (2021). Al-Qānūn fi’l Ṭibb (Urdu translation by Kantoori G.H.). Vol. III (Part II). New Delhi, Idara Kitabush Shifa, 1119-1124.
5) Samarqandi N. Sharah Asbab (Urdu translation by Hkm Kabiruddin). Vol. III. Deoband, Faisal Publications, 213-221.
6) Razi Z. Kitab al-Hawi i Tib. Vol. 11, Central Council for Research in Unani Medicine, Ministry of Health and Family Welfare, New Delhi, Govt. of India; c2004.
7) Jurjani I. Zhakhira Khawarizm Shahi (Urdu translation by Hadi Husain Khan). Idara Kitab-us-Shifa, New Delhi, YNM.
8) Arzani HMA. Tibb-e-Akbar (Urdu Translation by Hussain HM). Idara Kitab-us-Shifa, New Delhi, 617-628. Ahmad AUAM, Qamar Uddin, Ismail BA, Jabeen J. Etiopathogenesis and management of Waja’al-mafaṣ il (Rheumatoid arthritis): An evidence-based comprehensive review. International Journal of Research in Ayurveda and Pharmacy 2021;12(6):96-103. https://doi.org/10.7897/2277-4343.1206180
9) Khan MS, Ali SJ, Nayab M, Aziz A. Effect of massage with Roghan Biskhapra (oil of Trianthena portulacastrum L.) in Rheumatoid Arthritis: case reports of two patients. Journal of Herbal Sciences 2015;4(3):1-3.
10) Kulliyat (Urdu translation). CCRUM, New Delhi. 1987;384 385:420-421.
11) Tabri AR. Firdaus al Hikmat (Urdutranslation). Sheikh Mohammad Bashir & Sons, Lahore, 1417, 291-293, 308.
12) Majusi AA. Kamil-us-Sana (Urdu translation). Vol.2, Matba Munshi Nawal Kishore, Lucknow, 1889, 503-513, 521-522, 531- 534.
13) The basic principles of Unani: Treating the root cause. Happiest Health. https://www.happiesthealth.com
14) Sın̄ ā I. Al Qānūn i’l Ṭ ibb. Vol.3. Urdu translation by Ḥakım̄ Ghulām Ḥasnayn Kintūrı.̄ New Delhi:Idārā Kitāb al-Shifā . YNM. p.1119-1121.
15) Majoosi, Ali Bin Abbas, Kamil-Us-sanah (Translated by GulamHasnainKantoori), Vol. II, MunshiNawal Kishore Press, Lucknow, 1889; 507-513.
16) Jurjani, A.H., Zakheerah Khwarizm Shahi, vol.6 (Translated by Hadi Hussain Khan) Munshi Nawal Kishore Press, Lucknow, 1903; 637-646.
17) Warrell DA, Cox TM, Firth JD. Oxford Textbook of Medicine. th 5 ed. USA: Oxford University Press. 2010. p.35813600. https://doi.org/10.1093/med/9780199204854.001.1
18) National Formulary of Unani Medicine, Part-I. New Delhi: Government of India, Ministry of Health & Family Welfare, Department of AYUSH; 2006. p. 145-146.
19) Ganesan R, Doss HM, Rasool M. Majoon e Ushba, a polyherbal compound ameliorates rheumatoid arthritis via regulating inflammatory and bone remodeling markers in rats. Cytokine. 2016;77:115 126. https://doi.org/10.1016/j.cyto.2015.11.003 PMid:26546776
20) Ahmad S, Ansari JA, Ahmad R, Khan A, Arif M, et al. Anti arthritic potential of Colchicum luteum Linn. in experimental models of rheumatoid arthritis. Inflammopharmacology. 2026;34(2):451 463. doi:10.1007/s10787 025 00987 y.
21) Faghfoori Z, Javadivala Z, Khalili Y, Malek Mahdavi A. Effects of Trigonella foenum graecum (fenugreek) on rheumatoid arthritis: a systematic review. Immunopharmacol Immunotoxicol.2023;45(5):626 634. https://doi.org/10.1080/08923973.2023.2202298 PMid:37039783
22) Hadi V, Kheirouri S, Alizadeh M, Khabbazi A, Hosseini H. Effects of Nigella sativa oil extract on inflammatory cytokine response and oxidative stress in patients with rheumatoid arthritis: a randomized, double blind, placebo controlled clinical trial. Avicenna J Phytomed. 2016;6(1):34 43. PMID: 27247920.
23) Sharma R, Gupta A, Singh B, Kumar S. Network pharmacology and metabolomics reveal anti arthritic mechanisms of Lepidium sativum in rheumatoid arthritis models. Sci Rep. 2025;15:11234. doi:10.1038/s41598 025 11234 7.
24) Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO III, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis. 2010;69(9):1580 8. doi: 10.1136/ard.2010.138461
25) Ansari AH, Zulkifle M, Ali M. An analytical study of concordance between Mizaj and diseases in adult patients of NIUM Hospital, Bangalore. Ancient Sci Life. 2010;30:7 11.
26) Rahi T, Islam N, Pandith RA, Akbar S, Rafeeqi TA. Evaluation of oral and topical herbal formulations used in Unani medicine for treatment of psoriasis and its effect on inflammatory biomarkers: a randomized controlled clinical trial. Eur J Integr Med. 2022;54:102154. https://doi.org/10.1016/j.eujim.2022.102154
27) Ibn al-Bayṭār. (1999). Al Jame ul Mufradat e Advia wa al Aghzia (Urdu Translation). Vol III. (New Delhi, CCRUM).
28) Ibn Sina. (2010). Al-Qānūn fi’l Ṭibb (Urdu translation by Kantoori G.H.). Vol II. (New Delhi, Idara Kitabush Shifa).
29) Hailu T, Sharma R, Mann S, Gupta P, Gupta RK, Rani A. (2021). Determination of bioactive phytochemicals, antioxidant and antiinflammatory activity of Colchicum autumnale L.(Suranjan shireen). Indian Journal of Natural Products and Resources, 12(1): 52-60.
30) Suica-Bunghez IR, Ion RM, Teodorescu S, Sorescu A, Stirbescu RM, Stirbescu NM. (2017). Fitochemical and antioxidant characterization of Autumn Crocus (Colchicum autumnale) flowers and roots plant extracts. Journal of Science and Arts, 17(3):539-46.
31) Bhattacharjee SK. (2004). Handbook of Medicinal Plants, revised 4th ed. (Jaipur (Raj.) India. Pointer Publishers).
32) Ghani N. (2011). Khazā’in al-Adwiya. (Idara Kitab-Ul-Shifa. New Delhi).
33) Imboden JB, Hellmann DB, Stone JH. (2013). Current diagnosis & treatment: rheumatology. 3rd ed, 139,147.
34) Amin et al., (2006). Study of Bisfaij for Anti- arthritic effect in an animal model for Rheumatoid Arthritis. Unimed-Kulliyat, Vol II. (2): 27.
Published
Abstract Display: 55 
PDF Downloads: 59 PDF Downloads: 10 How to Cite
Issue
Section
Copyright (c) 2026 Humaira Bano , Md Hamza Ahmad , Abdullah Faizul Hasan , Badrudduja Khan
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.